I feel like I'm missing something. Is Uplinza funding separate from the National Decade against Post-Infectious Diseases?Possibly. Isatuximab wasn't mentioned explicitly, only her group.
Edit: speak of the devil
![]()
Postinfektiöse Erkrankungen - BMFTR
Gegen postinfektiöse Erkrankungen wie Long COVID oder ME/CFS fehlen bislang wirksame Behandlungsmöglichkeiten. Die Nationale Dekade gegen Postinfektiöse Erkrankungen entschlüsselt Ursachen und Mechanismen und schafft Stück für Stück die Basis zur Entwicklung neuer Therapieoptionen.www.bmftr.bund.de
From the linked page:
In 2026, for example, a newly designed Phase II study on the efficacy and safety of the monoclonal antibody Uplizna will start.
From previous post:
For this reason, the initial research funding guidelines will not aim to promote individual therapies or specific drug candidates.